Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model

November 21, 2017

Scientists at the University of Tampere (Finland) and the Karolinska Institutet (Sweden) have demonstrated that an enterovirus vaccine can protect against virus-induced diabetes in a mouse model for type 1 diabetes.

Type 1 diabetes is rising worldwide, and to date, the exact causes of the are not known. Enteroviruses (the most common virus affecting humans) are an environmental factor touted as a potential cause of the disease. However, no firm evidence exists proving their role. In this study, Stone et al. have taken an initial step to determine the involvement of these viruses through testing the efficacy of a novel prototype vaccine in preventing experimental type 1 diabetes after enterovirus infection. Vaccination of at risk-individuals with such a vaccine and the subsequent monitoring of disease onset could reveal a role for these viruses in type 1 diabetes. Furthermore, if enteroviruses were involved, vaccination with an enterovirus vaccine would provide a viable preventative treatment for virus-induced type 1 diabetes.

Type 1 diabetes is the most common, chronic, life-threatening disease in children. Finland and Sweden have the highest incidence of type 1 diabetes in the world with more than one in 200 suffering from the disease in Sweden. The disease is caused by the destruction of the cells in the pancreas that produce insulin, the hormone responsible for regulating blood sugar levels. There are currently no preventative treatments and this disease requires life-long insulin injections for survival. Type 1 diabetes is also associated with severe and life-shortening complications including cardiovascular disease, loss of eyesight and a risk of lower limb amputations, and as such, it puts a heavy burden on both the affected individual and the health care system at large.

Currently, there are no commercially available vaccines available for human use that target the enteroviruses that are associated with type 1 diabetes in humans. For the first time, this study by Stone et al. reports that the vaccine prevents diabetes induced by enteroviruses in a clinically relevant model for type 1 diabetes. Furthermore, it also protected against other signs of infection that were seen in control animals and it had no adverse effects on vaccinated animals.

"These exciting results showing that the vaccine completely protects against virus-induced diabetes indicate the potential that such a vaccine has for elucidating the role of enteroviruses in human type 1 diabetes" says Prof. Malin Flodström-Tullberg at the Karolinska Institutet whose group were responsible for the pre-clinical studies.

The researchers are keen to continue pursuing these studies as confirmed by Dr Vesa Hytönen, who produced the prototype vaccine: "The model described in this paper provides an excellent platform to test further enterovirus vaccines containing a greater number of potential diabetogenic viruses. Through these proof-of-concept studies, we hope to develop and experimentally validate an enterovirus vaccine similar to the commonly used poliovirus vaccine, which has the potential to establish whether enteroviruses play a role in type 1 diabetes."

Work is currently ongoing at the University of Tampere to develop a vaccine that targets a greater number of viruses than the single vaccine described in this study, and all of the proposed viruses have been implicated in type 1 . This experimental model provides an exciting opportunity for further proof-of-concept studies before progress to a clinical set-up in humans.

"The experiments here are important steps towards the clinical use of novel enterovirus vaccines. Such a is under further development by Vactech Ltd. and its collaborator Provention Bio for testing in a clinical setting," says professor Heikki Hyöty, University of Tampere, an author in this study and one of the pioneers in this research field.

Explore further: New evidence for the role of a specific virus causing type 1 diabetes

More information: Virginia M. Stone et al, A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes, Diabetologia (2017). DOI: 10.1007/s00125-017-4492-z

Related Stories

New evidence for the role of a specific virus causing type 1 diabetes

October 22, 2013
Type 1 diabetes is a disease caused by the destruction of the insulin-producing cells in the pancreas. It is often diagnosed in childhood and requires life-long treatment with daily insulin injections. It is associated with ...

Study suggests enterovirus infections linked with autoimmunity that leads to type 1 diabetes

January 9, 2017
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that children with type 1 diabetes (T1D) have a higher incidence of enterovirus infections prior to experiencing ...

The risk of type 1 diabetes not increased by swine flu vaccine Pandemrix

October 9, 2017
There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy. However, a new study of children from Sweden and Finland shows that the vaccine increased ...

Detection of enterovirus infection in pancreatic islets in patients newly diagnosed with type 1 diabetes

December 16, 2014
Norwegian scientists with European partners have found evidence for the presence of enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade enteroviral ...

Enterovirus infection linked to incidence of T1DM in children

October 20, 2014
(HealthDay)—The risk of type 1 diabetes is increased for children diagnosed with enterovirus infection, according to a study published online Oct. 17 in Diabetologia.

Recommended for you

Personalized blood sugar goals can save diabetes patients thousands

December 11, 2017
A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health ...

Kidney disease increases risk of diabetes, study shows

December 11, 2017
Diabetes is known to increase a person's risk of kidney disease. Now, a new study from Washington University School of Medicine in St. Louis suggests that the converse also is true: Kidney dysfunction increases the risk of ...

Type 2 diabetes is not for life

December 5, 2017
Almost half of the patients with Type 2 diabetes supported by their GPs on a weight loss programme were able to reverse their diabetes in a year, a study has found.

Skipping breakfast disrupts 'clock genes' that regulate body weight

November 30, 2017
Irregular eating habits such as skipping breakfast are often associated with obesity, type 2 diabetes, hypertension and cardiovascular disease, but the precise impact of meal times on the body's internal clock has been less ...

Type 2 diabetes has hepatic origins

November 28, 2017
Affecting as many as 650 million people worldwide, obesity has become one of the most serious global health issues. Among its detrimental effects, it increases the risk of developing metabolic conditions, and primarily type ...

Critical link between obesity and diabetes has been identified

November 28, 2017
UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.